Purpose: To assess the feasibility of using recombinant adenovirus vectors
to transduce the human lens epithelial cells (LECs) involved in posterior c
apsule opacification (PCO).
Setting: Department of Ophthalmology and Molecular Medicine Unit, Universit
y of Manchester, Manchester, United Kingdom.
Methods: Seventeen human lens capsules were maintained in organ culture to
allow LECs to proliferate onto the posterior capsule. Partly covered and co
mpletely covered capsules were infected with a recombinant adenovirus vecto
r RAd35, encoding for the marker gene beta-galactosidase at plaque-forming
units per milliliter (pfu/mL) ranging from 10(7) to 10(10) for up to 48 hou
rs. Assessment of infection and transduction of the marker gene were achiev
ed by calculating the percentage of cells exhibiting X-gal staining both ma
croscopically and microscopically.
Results: Staining appeared to be dependent on virus dose, with most intense
staining at doses of 10(8) and 10(9) pfu/ml with decreased staining at hig
her and lower viral doses. Microscopic assessment demonstrated that all cel
ls expressed beta-galactosidase when infected with 10(9) piu, 84% at 10(8)
pfu, and 45% at 10(7) pfu. At 10(10) pfu, some cytotoxicity was observed.
Conclusions: These results indicate that recombinant adenoviruses can be us
ed to transfer genes to the LECs involved in PCO. The transfer of cytotoxic
genes after cataract surgery may be considered a preventive measure for PC
O. (C) 2000 ASCRS and ESCRS.